Skip to main content

Table 1 Patient Stratification by Prostate Cancer Risk and Treatment Modality with Treatment and Complication Costs for Radical Prostatectomy and Radiotherapy

From: Cost implications of PSA screening differ by age

 

Active Surveillance

Radical Prostatectomy

Radiotherapy

Cryotherapy

Primary Androgen Deprivation Therapy

%

 Low

9.2%

56.8%

23.3%

3.1%

7.6%

 Intermediate

4.8%

52.9%

25.8%

4.5%

11.9%

 High

3.2%

32.2%

25.6%

6.1%

32.8%

 Unknown

9.9%

42.2%

26.3%

2.6%

18.9%

N

 Low

5

28

11

2

4

 Intermediate

2

26

13

2

6

 High

1

6

5

1

7

 Unknown

2

7

4

0

3

 Total

10

67

33

5

20

Total cost by treatment as a percentage of total cost of screening and treatment

 

31.3%

32.0%

  

Complication rate

 

17.0%

1.6%

  

Total complication cost by treatment as a percentage of total cost of screening and treatment

 

10.4%

0.11%

  

Total treatment cost as a percentage of total screening and treatment cost

66.6%

    
  1. Source of cost estimate is insurance claim data from a commercial health plan in the mid-Atlantic
  2. Active surveillance, cryotherapy, and primary androgen deprivation therapy are not included in total cost amount as they are not primary modalities of active therapy, which we focused our analysis on